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Background: Heart failure (HF) and atrial fibrillation (AF) are twin epidemics with poor prognosis in pts with type 2 diabetes mellitus (T2DM). 
Obstructive sleep apnea (OSA) is an important correlate of T2DM, but its role in HF+AF is unclear, as is the role of underlying lung disease. We sought 
to evaluate clinical predictors of new HF and AF in T2DM.
Methods: 914 consecutive T2DM pts (age 56±11y) without prior HF or AF and with a negative stress echo were enrolled in an observational study, 
after exclusion of prior cardiac surgery, > mild valvular heart disease, or ejection fraction < 50%. Demographics, clinical assessments based on 
standards of diabetes care, co-morbidities, and treatment with insulin, diuretics, beta-blockers, statins, ace-inhibitors and aspirin were collected 
at the time of stress echo. Pts were followed for up to 8 y for HF+AF, and best predictors of endpoints were sought by using nested Cox proportional 
hazard models.
Results: 22 new HF and 25 new AF developed during a mean time of 4.8 y. OSA and asthma were associated with outcome in univariate and all 
adjusted models (Table), independent of socio-economic class, diabetes care and clinical predictors.
Conclusion: OSA and asthma are associated with HF+AF in T2DM.
Table: Impact of Baseline OSA and Asthma on HF+AF in Cox Models: 
OSA Asthma
Hazard Ratio (95% 
CI)
p-value
Hazard Ratio (95% 
CI)
p-value
Univariate 2.3 (1.01-5.04) 0.046 2.3 (1.1, 4.8) 0.037
Multivariate (OSA, Asthma) with:
Age, gender 2.6 (1.1-5.9) 0.025 2.6 (1.2-5.6) 0.019
Age, gender, race, poverty 2.6 (1.2-6.1) 0.022 2.5 (1.2-5.6) 0.021
Age, gender, ejection fraction, left atrial volume, nonoptimal systolic or diastolic 
pressure at baseline echo
2.5 (1.1-5.6) 0.034 2.5 (1.1-5.6) 0.022
Age, gender , hypertension, obesity, CAD, resistant hypertension, depression, anxiety, 
neuropathy, nephropathy
2.5 (1.1-5.7) 0.035 2.5 (1.1-6.0) 0.021
Age, gender, family history, smoking, hypertension, CAD 2.4 (1.04-5.5) 0.039 2.7 (1.2-6.0) 0.013
Age, gender, treatment 2.4 (1.03-5.5) 0.042 2.5 (1.1-5.6) 0.023
Age, Gender, nonoptimal control of diabetes, HDL, triglyceride and creatinine (2011 
Diabetes Standards of Medical Care Guidelines )
2.6 (1.1-5.9) 0.0247 2.6 (1.2-5.7) 0.018
